Related Experiment Video
Updated: Aug 10, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Impact of the French Infectious Diseases Society's (SPILF) proposals for shorter antibiotic therapies
1Infectious diseases department, université de Lorraine, CHRU de Nancy, 54000 Nancy, France.
Objective:
To compare the practices of French infection specialists related to antibiotic therapy duration between 2016 and 2018.
Methods:
We conducted two identical surveys (in 2016 and 2018) targeting hospital-based infection specialists (medical physicians, pharmacists) who gave at least weekly advice on antibiotic prescriptions. The questionnaire included 15 clinical vignettes. Part A asked about the durations of antibiotic therapies they would usually advise to prescribers, and part B asked about the shortest duration they would be willing to advise for the same clinical situations.
Results:
We included 325 specialists (165 in 2016 and 160 in 2018), mostly infectious disease specialists (82.4%, 268/325), members of antibiotic stewardship teams in 72% (234/325) of cases. Shorter antibiotic treatments (as compared with the literature) were advised to prescribers in more than half of the vignettes by 71% (105/147) of respondents in 2018, versus 46% (69/150) in 2016 (P<0.001). Guidelines used by participants displayed fixed durations for 77% (123/160) of cases in 2018 versus 21% (35/165) in 2016. Almost all respondents (89%, 131/160) declared they were aware of the 2017 SPILF's proposal.
Conclusion:
The release of guidelines promoting shorter durations of antibiotic therapy seems to have had a favourable impact on practices of specialists giving advice on antibiotic prescriptions.
Insights
French infection specialists increasingly advised shorter antibiotic therapy durations between 2016 and 2018. This shift aligns with new guidelines, indicating a positive impact on antibiotic stewardship practices.
Area of Science:
- Infectious Diseases
- Antimicrobial Stewardship
- Clinical Practice Guidelines
Background:
- Antibiotic therapy duration is a key component of antimicrobial stewardship.
- Variability in recommended durations can impact treatment outcomes and resistance.
- Understanding specialist practices is crucial for optimizing antibiotic use.
Purpose of the Study:
- To compare French infection specialists' antibiotic therapy duration recommendations in 2016 versus 2018.
- To assess the influence of updated guidelines on specialist practices.
Main Methods:
- Two identical surveys administered to hospital-based infection specialists in 2016 and 2018.
- Surveys included 15 clinical vignettes assessing usual and shortest recommended antibiotic therapy durations.
- Participants were medical physicians and pharmacists advising on antibiotic prescriptions.
Main Results:
- A significant increase in advising shorter antibiotic durations was observed in 2018 (71%) compared to 2016 (46%).
- Guideline adherence for fixed durations rose from 21% in 2016 to 77% in 2018.
- Awareness of the 2017 SPILF guidelines was high among specialists in 2018 (89%).
Conclusions:
- The introduction of guidelines advocating shorter antibiotic therapy durations positively influenced specialist practices.
- These findings suggest successful implementation of evidence-based recommendations in clinical settings.
- Optimized antibiotic prescribing through guideline adoption can enhance antimicrobial stewardship.
More Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Microbiota Modulation by Antibiotics
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial DNA Synthesis
Clinical Significance of Antibiotic Resistance